Efficacy and safety of etanercept in patients with psoriasis and hepatitis C

European Journal of Dermatology

Volumn 20, Issue 6, 2010, Pages 808-809

  Ventura, Filipa ^a   Gomes, Joana ^a   Duarte, Maria Da Luz ^a   Fernandes, José Carlos ^a   Brito, Celeste ^a  

^a HOSPITAL DE BRAGA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CLOBETASOL PROPIONATE; CYCLOSPORIN; ETANERCEPT; GAMMA GLUTAMYLTRANSFERASE; VIRUS RNA;

ADULT; CASE REPORT; DRUG EFFICACY; DRUG SAFETY; HEPATITIS C; HUMAN; LETTER; MALE; NONHUMAN; PSORIASIS;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIVIRAL AGENTS; FEMALE; HEPATITIS C; HUMANS; IMMUNOGLOBULIN G; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PSORIASIS; RECEPTORS, TUMOR NECROSIS FACTOR; TREATMENT OUTCOME;

EID: 78649894857     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2010.1065     Document Type: Letter

References (6)

1. De Simone C, Paradisi A, Capizzi R, et al. Etanercept therapy in two patients with psoriasis and concomitant hepatitis C. J Am Acad Dermatol 2006; 54: 1102-4. (Pubitemid 43732395)
2. Khanna M, Shirodkar MA, Gottlieb AB. Etanercept therapy in patients with autoimmunity and hepatitis C. J Dermatol Treat 2003; 14: 229-32. (Pubitemid 37474535)
3. Li S, Kaur PP, Chan V, Berney S. Use of tumor necrosis factor-alpha (TNF-alpha) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients. Clin Rheumatol 2009; 28: 787-91.
4. Magliocco MA, Gottlieb AB. Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: report of 3 cases. J Am Acad Dermatol 2004; 51: 580-4.
5. Piccolo D, Cesare AD, Fargnoli MC, et al. Effective control of psoriasis by etanercept in a patient with HCV-related diseases. Eur J Dermatol 2008; 18: 459-60. (Pubitemid 352031859)
6. Zein NN. Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study. J Hepatol 2005; 42: 315-22.